A Study to Evaluate the Efficacy and Safety of Orally Administered Extract of Orthosiphon Stamineus (NuvastaticTM-C5OSEW5050ESA) in Patient With Breast Cancer Undergoing Chemotherapy

NCT07669506 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Fatigue
Quality of Life
Chemotherapy, Adjuvant

Interventions

DRUG: Nuvastatic ™
DRUG: Placebo

Sponsor

Natureceuticals Sdn Bhd